Parallel Advisors’s Psyence Biomedical PBM Stock Holding History
Bought
Maintained
Sold
Other funds holding PBM
Parallel Advisors's PBM Position: Q3 2026 in Review
Parallel Advisors held its Psyence Biomedical (PBM) position steady in Q3 2026 at 151,250 shares worth $575K. The position accounts for 0.01% of the portfolio, ranked #760.
Parallel Advisors first reported a position in PBM in Q2 2025 and has held it in 6 quarters since. The position peaked at $687K in Q4 2025. 10 funds tracked by Wall St. Rank hold PBM as of Q3 2026.
- Parallel Advisors held 151,250 shares of Psyence Biomedical worth $575K as of Q3 2026.
- Parallel Advisors left its Psyence Biomedical share count unchanged in Q3 2026.
- Psyence Biomedical made up 0.01% of Parallel Advisors's portfolio in Q3 2026, its #760 holding.
- Parallel Advisors first reported a position in Psyence Biomedical in Q2 2025 and has held it in 6 quarters since.
- Parallel Advisors's Psyence Biomedical position peaked at $687K in Q4 2025.
- 10 funds tracked by Wall St. Rank held Psyence Biomedical as of Q3 2026.
Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.